New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...
(From left) Principal Advisor the eCEOs (M) Sdn Bhd who served as moderator; Raja Datuk Dr Abdul Aziz Raja Adnan, Chief Executive Officer of MyPOWER Corporation Asdirhyme Abd Rasib, Nuclear Investment ...
Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Against this backdrop, the ...
Scientists are getting closer to figuring out how amyloid immunotherapy causes ARIA, and perhaps how to prevent it. At last month’s AD/PD conference in Copenhagen, Denmark, the spotlight was on innate ...
C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
Omeros is an innovative, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with ...
Rather than focusing on counter-terrorism operations, dialogue should be supported as a way to tackle local dynamics sustaining the insurgency. Despite sustained counter-insurgency operations and ...
FDA Fast Track designation has been granted to CTx001 for Geographic Atrophy secondary to Age-related Macular Degeneration CTx001 is an investigational AAV-based gene therapy designed to modulate ...
It's been a long time coming: Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the Seattle biotech has finally scored its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results